Opportunity Information: Apply for PAR 10 072
Apply for PAR 10 072
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Mechanism for Time Sensitive Drug Abuse Research (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Jan 4, 2010 and posted on Jan 4, 2010.
- Applicants must submit their applications by Dec 10, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Independent school districts County governments Others (see text field entitled Additional Information on Eligibility for clarification) City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Native American tribal governments (Federally recognized) Private institutions of higher education Public and State controlled institutions of higher education State governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Mechanism for Time Sensitive Drug Abuse Research (R01) opportunity (Funding Opportunity Number PAR-10-072) is a National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) funding announcement designed to support substance abuse prevention and treatment services research when the window to study an important real-world change is brief and could be lost if investigators had to wait for the standard NIH review and award timelines. The core idea is to make it possible to rapidly launch rigorous empirical research in situations where service delivery, financing, policy, or environmental conditions are shifting quickly, such as major changes in health care systems, new payment models, policy reforms, or the effects of natural or man-made disasters. The program is explicitly focused on research opportunities that emerge unexpectedly or evolve rapidly, where delay would mean the chance to collect critical data or evaluate impacts in real time would disappear.
A study is considered appropriate for this FOA when three key conditions are met. First, the project needs to be clearly valuable scientifically and feasible to carry out, meaning the research question, approach, and ability to execute should be well supported and not speculative. Second, the work must genuinely require rapid review and funding in order to answer the question, reflecting that the circumstances creating the research opportunity will not remain stable long enough for a traditional grant cycle. Third, the knowledge to be gained must be time sensitive, in the sense that going through the regular NIH schedule would likely cause the field to miss an uncommon, scientifically significant opportunity to learn from a real-world event or transition. In practice, this means applicants must make a convincing case that the phenomenon being studied is happening now, that meaningful baseline or early-transition data would be lost with delay, and that starting the project quickly is essential.
The mechanism of support is the NIH Research Project Grant (R01), which generally supports more mature, full-scale research projects than exploratory mechanisms. This FOA is described as running in parallel with a companion announcement of the same scientific scope that uses the R21 Exploratory/Developmental Grant mechanism (PAR-07-345), signaling that investigators can choose an application route that matches the maturity and scale of their proposed work. The announcement notes that awards are contingent on the availability of funds and the receipt of a sufficient number of highly meritorious applications, and it does not require cost sharing or matching.
Eligibility is broad and includes many types of domestic organizations and governments involved in research and public service. Eligible applicants include public and private institutions of higher education, nonprofit organizations (including both 501(c)(3) and non-501(c)(3) entities), for-profit organizations (including small businesses), independent school districts, and various levels of government such as city/township, county, state, special district, and certain public housing authorities/Indian housing authorities. It also includes Native American tribal governments (federally recognized) and tribal organizations (including those other than federally recognized governments), as well as U.S. territories or possessions and regional organizations. The eligibility list also explicitly calls out mission-focused categories often highlighted in federal funding, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and faith-based or community-based organizations, along with eligible federal agencies.
Administratively, the opportunity falls under the NIH and is categorized as a discretionary grant in the education and health domain, with CFDA number 93.279 (Drug Abuse and Addiction Research Programs). The posting and creation date listed are January 4, 2010, with an original and current closing date of December 10, 2012, and an archive date of January 10, 2013, indicating the announcement is no longer open but remains useful as a reference point for the type of time-sensitive, rapid-response services research NIDA has sought to support. The full announcement was made available through the NIH grants guide, and NIH Office of Extramural Research (OER) webmaster contacts were provided for access or linking problems.
FAQs: Mechanism for Time Sensitive Drug Abuse Research (R01) (PAR-10-072)
What is the Mechanism for Time Sensitive Drug Abuse Research (R01) opportunity (PAR-10-072)?
PAR-10-072 is a National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) funding announcement designed to support substance abuse prevention and treatment services research when a real-world change is happening quickly and the opportunity to study it would likely be lost under standard NIH review and award timelines.
What is the main purpose of this funding announcement?
The purpose is to enable rapid launch of rigorous empirical research tied to brief windows of opportunity, such as sudden or fast-moving changes in service delivery, financing, policy, or environmental conditions that affect substance abuse prevention and treatment services.
What kinds of real-world changes is this FOA meant to address?
This FOA is aimed at situations where conditions are shifting quickly, including major changes in health care systems, new payment models, policy reforms, and the impacts of natural or man-made disasters, when those changes create a short-lived chance to capture critical data or evaluate impacts in real time.
What does "time sensitive" mean in this context?
"Time sensitive" means the knowledge to be gained depends on studying an event or transition as it happens, and going through the regular NIH schedule would likely cause investigators to miss an uncommon and scientifically significant opportunity to collect baseline or early-transition data.
Why does this program emphasize rapid review and funding?
The program exists because some research opportunities emerge unexpectedly or evolve rapidly. If investigators had to wait for a traditional grant cycle, the conditions creating the opportunity might change, baseline measures could be lost, and the chance to evaluate the effects of the change in real time could disappear.
What are the key conditions that make a study appropriate for this FOA?
A study is considered appropriate when three conditions are met: (1) the project is scientifically valuable and feasible (not speculative), (2) the work genuinely requires rapid review and funding to answer the question, and (3) the knowledge to be gained is time sensitive such that delay would likely cause the field to miss the opportunity.
How should applicants justify that rapid funding is truly necessary?
Applicants are expected to make a convincing case that the phenomenon is happening now, that meaningful baseline or early-transition data would be lost with delay, and that starting quickly is essential to capture scientifically important information during the short window.
What is the mechanism of support for PAR-10-072?
The mechanism of support is the NIH Research Project Grant (R01), which generally supports more mature, full-scale research projects rather than exploratory studies.
Is there a related opportunity for smaller or more exploratory projects?
Yes. This FOA is described as running in parallel with a companion announcement of the same scientific scope using the R21 Exploratory/Developmental Grant mechanism (PAR-07-345), allowing investigators to choose an application route that matches the maturity and scale of their work.
Who is the sponsoring agency?
The sponsoring agency is the National Institute on Drug Abuse (NIDA) within the National Institutes of Health (NIH).
What research area is this opportunity focused on?
It is focused on substance abuse prevention and treatment services research, particularly research that can rigorously evaluate the effects of fast-moving real-world changes on services, systems, or outcomes.
Is cost sharing or matching required?
No. The announcement specifies that it does not require cost sharing or matching.
Are awards guaranteed if an application is submitted?
No. The announcement notes that awards are contingent on the availability of funds and the receipt of a sufficient number of highly meritorious applications.
What types of organizations are eligible to apply?
Eligibility is broad and includes many domestic organizations and governments involved in research and public service. Eligible applicants include public and private institutions of higher education; nonprofit organizations (both 501(c)(3) and non-501(c)(3)); for-profit organizations (including small businesses); independent school districts; and multiple levels of government (city/township, county, state, special district), including certain public housing authorities/Indian housing authorities.
Are tribal governments and tribal organizations eligible?
Yes. The eligibility list includes Native American tribal governments (federally recognized) and tribal organizations, including those other than federally recognized governments.
Are U.S. territories or regional organizations eligible?
Yes. Eligibility includes U.S. territories or possessions and regional organizations.
Are institutions like HBCUs, Hispanic-serving institutions, and TCCUs included in eligibility?
Yes. The eligibility list explicitly calls out Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and faith-based or community-based organizations.
Are federal agencies eligible to apply?
Yes. The eligibility list includes eligible federal agencies.
How is this opportunity categorized within federal assistance programs?
It is administered under NIH and categorized as a discretionary grant in the education and health domain, with CFDA number 93.279 (Drug Abuse and Addiction Research Programs).
When was this funding opportunity posted, and is it still open?
The posting/creation date is listed as January 4, 2010. The original and current closing date is December 10, 2012, with an archive date of January 10, 2013. Based on those dates, the announcement is no longer open and remains available as a reference.
Where was the full announcement made available?
The full announcement was made available through the NIH grants guide.
Who is listed for help with access or linking problems?
The NIH Office of Extramural Research (OER) webmaster contacts were provided for access or linking issues related to the announcement.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Technology Development for High Throughput Structural Biology Research (P01)
Previous opportunity: NIH Support for Conferences and Scientific Meetings (Parent R13/U13)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 10 072
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 10 072) also looked into and applied for these:
| Funding Opportunity |
|---|
| SBIR Phase II Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics toward Commercialization (R44) Apply for RFA CA 10 009 Funding Number: RFA CA 10 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Image Guided Cancer Interventions (SBIR R43/R44) Apply for PA 10 079 Funding Number: PA 10 079 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Image Guided Cancer Interventions (STTR R41/R42) Apply for PA 10 080 Funding Number: PA 10 080 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Shared Instrumentation Grant Program (S10) Apply for PAR 10 082 Funding Number: PAR 10 082 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Systems Biology, HIV/AIDS, and Substance Abuse (R01) Apply for RFA DA 10 014 Funding Number: RFA DA 10 014 Agency: National Institutes of Health Category: Education Health Funding Amount: $750,000 |
| Pre Application for the 2010 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (X02) Apply for PAR 10 095 Funding Number: PAR 10 095 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| 2010 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (DP1) Apply for RFA DA 10 013 Funding Number: RFA DA 10 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for Substance Related Disorders (R01) Apply for RFA DA 10 018 Funding Number: RFA DA 10 018 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Deep Sequencing and Analysis of Pharmacogenomic Regions Discovery and Analysis of Genetic Variants Contributing to Drug Abuse and Addiction (R01) Apply for RFA DA 10 019 Funding Number: RFA DA 10 019 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Institutional Clinical and Translational Science Award (U54) Apply for RFA RM 10 001 Funding Number: RFA RM 10 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Technology Based Adherence Interventions for Substance Abusing Populations with HIV (R01) Apply for PAS 10 097 Funding Number: PAS 10 097 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Technology Based Adherence Interventions for Substance Abusing Populations with HIV (R34) Apply for PAS 10 098 Funding Number: PAS 10 098 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Chronic Co Morbid Conditions in HIV U.S. Adults on Highly Effective Anti Retroviral Therapy (R01) Apply for RFA NR 10 001 Funding Number: RFA NR 10 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Chronic Co Morbid Conditions in HIV U.S. Adults on Highly Effective Anti Retroviral Therapy (R21) Apply for RFA NR 10 002 Funding Number: RFA NR 10 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (Parent F31) Apply for PA 10 108 Funding Number: PA 10 108 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Comprehensive Partnerships to Reduce Cancer Health Disparities (Limited Competition U54) Apply for RFA CA 10 503 Funding Number: RFA CA 10 503 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Advancing Palliative Care Research for Children Facing Life Limiting Conditions (R21) Apply for RFA NR 10 007 Funding Number: RFA NR 10 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Advancing Palliative Care Research for Children Facing Life Limiting Conditions (R01) Apply for RFA NR 10 006 Funding Number: RFA NR 10 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Common Pathogenetic Mechanisms of Lung Cancer and COPD (R01) Apply for RFA HL 11 002 Funding Number: RFA HL 11 002 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Collaborative Clinical Trials in Drug Abuse (Collaborative R01) Apply for PAR 10 099 Funding Number: PAR 10 099 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 10 072", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.